Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
3i sells Formel D to Atlantik Advisors after prolonged losses
Financial investor 3i has sold its majority stake in Formel D to Atlantik Advisors (AA AcquiCo 9) after the company recorded continuous double-digit million euro losses from 2018 to 2024. Although Formel D experienced temporary revenue growth, it never regained its 2019 peak; a global restructuring program including headcount reductions has so far failed to deliver the hoped-for turnaround. Atlantik Advisors will act as an interim shareholder, oversee the restructuring outside of insolvency proceedings and is expected to reorganize the company over about two to three years with a view to a later resale. Success will depend heavily on the still-weak auto sector, declining orders and rising price and competitive pressure. » More on wiwo.de
3i pays 0.84 GBP dividend for 2026 and raises payout to 765.00 million GBP
At the annual general meeting on 25 June 2026, 3i approved a dividend of 0.84 GBP for 2026, an increase of 15.07% year on year. The total distribution amounts to 765.00 million GBP, the ex-dividend date is 26 June 2026, and the dividend yield for 2026 is 3.47%. FactSet expects a dividend of 0.97 GBP for 2027 (estimated yield 3.81%). 3i has a market capitalization of 22.934 billion GBP, a P/E ratio of 4.52 and a five-year total return (price + dividends) of 231.73%. » More on finanzen.net
Strong NAV growth at 3i Group, shares fall after market concerns
3i Group reports a 19% NAV increase to £30.30 and a return on equity of 22% for the year ended 31 March 2026, driven mainly by the holding Action, which contributed £3.5bn to the valuation uplift. The dividend is raised 15% to £0.845. Despite the strong numbers, the stock fell 12.39% in premarket trading as investors fear geopolitical risks and valuation uncertainties in the portfolio. Management announces further store expansion for Action and a focus on a strong balance sheet and strategic investments. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | March 2026 | YoY |
|---|---|---|
| Revenue | 2.36bn | - |
| Gross profit | 2.36bn | - |
| Net profit | 2.3bn | - |
| EBITDA | 2.3bn | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €28.76bn |
Number of shares | 1.02bn |
52-week high/low | €53.71 - €21.80 |
Dividend yield | 3.56% |
Dividends TTM | €0.98 |
Beta | 1.63 |
P/E ratio | 4.42 |
PEG ratio | 1.54 |
P/B ratio | 0.78 |
P/S ratio | 4.31 |
Company profile
3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; and leisure. In the healthcare sector, the firm focuses on pharmaceuticals and biotechnology including specialty pharma, generics / OTC, drug delivery, and animal health; healthcare Services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in community facilities, as well as operational services such as outsourced support, clinical services and B2B contract services; medical devices and technology including devices, medical equipment and consumables, diagnostics, and healthcare IT. In the industrial sector, it focuses on automotive, chemicals, construction and building products, electronics and electrical components, flow control and filtration, life science manufacturing, mobility, packaging, software, oil, gas and power. Through 3i BIFM Limited and 3i Infrastructure plc the firm makes infrastructure investments where it focuses principally on the utilities including energy transmission and storage, electricity and gas distribution, water, power generation, and communication network; transportation including airports, ports, ferries, toll roads, and rail; and social infrastructure sector including primary and secondary PFI, public private partnerships, healthcare, education, and government accommodation. In infrastructure it invests primarily in utilities, transportation and social infrastructure in the United Kingdom, France, Italy, Europe, and Ireland. The firm prefers to invest in companies across Europe, France, United States, South America, and Asia. It seeks to make new investments in Northern Europe and North America. The firm typically invests between €5 million ($5.59125 million) and €300 million ($335.475 million) in companies with an enterprise value typically between €100 million ($111.825 million) and €500 million ($559.125 million) and sales value between €80 million ($89.46 million) and €1500 million ($1677.38 million). It seeks to take either majority or minority stakes. It seeks to take a board seat in its portfolio companies with regards to infrastructure investments. The firm invests through a combination of third-party and proprietary capital. It invests through its personal capital. 3i Group plc was founded in 1945 and is based in London, United Kingdom with additional offices across Europe, North America, and Asia.
| Name | 3i Group |
| CEO | Simon Alexander Borrows |
| Headquarters | London,
gl United Kingdom |
| Website | |
| Sector | Financials |
| Industry | Capital Markets |
| IPO | 18/07/1994 |
| Employees | 223 |
Ticker symbols
| Exchange | Symbol |
|---|---|
London Stock Exchange | III.L |
Pnk | TGOPF |
Frankfurt | IGQ5.F |
Düsseldorf | IGQ5.DU |
London | III.L |
SIX | IGQ5.SW |
München | IGQ5.MU |